Gefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

Clinical trial NCT00024089 · COMPLETED

Trial details

NCT number: NCT00024089
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer

Start date: 2001-07-01
Primary completion: 2006-03-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.